Scientific Program

Chairpersons:
Elianne Vrijlandt - Groningen, The Netherlands
Michael Fayon - Bordeaux, France

1. SARS CoV2 and Age - Transmission, Disease Manifestations and Mechanisms.
Renato Cutrera - Rome Italy

2. Strategies to Prevent SARS Cov2 Infection: Vaccines Current States?
Elizabeth Whittaker - London, UK

3. Clinical Adaptations post COVID19 in LMICs and HICs.
Manuel Soto-Martinez - San José, Costa Rica (15')
Sejal Saglani - London, UK (15')

1. Neonatal Pulmonology - Year in Review.
Amir Kugelman - Haifa, Israel

2. Congenital Lung Malformation Radiology.
Paul Guillerman - Houston, USA

3. Respiratory Outcome of Moderate/Late Preterm Infants.
Elianne Vrijlandt - Groningen, The Netherlands

1. LCI Update in Clinical and Research Applications.
   Monika Gappa - Düsseldorf, Germany
   
   
2. Change in FEV1 and FENO Measurements as Predictors of Future Asthma Outcomes in Children.
   Marielle Pijnenburg - Rotterdam, The Netherlands
   
   
3. The Lower Respiratory Airways Wall in Health and Disease.
   Michael Fayon - Bordeaux, France

1. Long-term Consequences of Childhood Respiratory Diseases.
Andrew Bush - London, UK

2. E-Cigarettes Use in Children and Adolescents.
Thomas Ferkol - Saint-Louis, USA

3. Young Investigator's Oral Communications

J – 71   Use of Optoelectronic Plethysmography to Assess The Ventilatory Response to Exercise in School-Aged Children Born Preterm.
Rebecca Naples – Newcastle Upon Tyne, UK

M – 61 Anemia, a Risk Factor for Acute Lower Respiratory Tract Infection in Children Under 5 Years of Age.
Nabila Akand – Dhaka, Bangladesh

C - 158  Comparison Between Three Clinical Scoring Instruments To Predict Disease Severity and Risk Of PICU Admission in Infants with Acute Bronchiolitis.
Basel Mamdouh Habra – Doha, Qatar

1. Immune Response to Viruses: Impact on Clinical Presentation of Respiratory Disease during Childhood.
Adnan Custovic - London, UK

2. The Effect of Climate Change on Respiratory Health in Children - Now and the Future.
Peter Le Souef - Perth, Australia

3. Young Investigator's Oral Communications

M – 137 Prevalence and Impact of Risk Factors for Poor Asthma Outcomes in a Third Level Specialist-Managed Patient Cohort in Costa Rica: A Real-Life Study.
Diana Carolina Ortega Saborío – San Jose, Costa Rica

O – 130 Flexible Bronchoscopy Findings in Infants Between 0-6 Months: Indications, Clinical Findings and Outcome.
Beste Ozsezen – Ankara, Turkey

I - 242 Cost-Effectiveness of Peak Flow-Based Asthma Action Plan in Children: A Randomized Controlled Trial.
Muenprae Jantanakul – Bangkok, Thailande

1. Early RSV Bronchiolitis and Childhood Wheezing and Asthma.
Louis Bont - Utrecht, The Netherlands

2. Phenotype-Based Management of Preschool Wheeze.
Sejal Saglani - London, UK

3. Prevention Strategies for Preschool Wheeze and Asthma Development.
Fernando Martinez - Tucson, USA

1. The Use of Aerosol Antibiotics in CF.
   Isabelle Sermet-Gaudelus - Paris, France
   
   
2. Systemic Drug Delivery and Immunizations Using the Airways as Portal.
   Bruce Rubin - Richmond, USA
   
   
3. Aerosoltherapy in the time of COVID.
   Israel Amirav - Tel Aviv, Israel
   

Chairpersons:
Elianne Vrijlandt - Groningen, The Netherlands
Michael Fayon - Bordeaux, France

Discussants:
Andrew Bush - London, UK
Andrew Colin - Miami, USA
Giovanni Rossi - Genoa, Italy
Matthias Griese - Munich, Germany

4 Cases:
Selected among accepted abstracts.